Vanda Pharmaceuticals Inc...

4.50
-0.09 (-1.96%)
At close: Apr 01, 2025, 3:59 PM
4.64
3.14%
After-hours: Apr 01, 2025, 07:56 PM EDT

Vanda Pharmaceuticals Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 102.32M 135.82M 135.03M 52.07M 61.03M
Short-Term Investments 272.33M 252.44M 331.83M 380.74M 306.71M
Long-Term Investments n/a n/a 469K 519K 525K
Other Long-Term Assets 9.1M 9.98M 10.91M 7.63M 6.12M
Receivables 47.1M 34.16M 33.51M 32.47M 30.04M
Inventory 1.73M 1.36M 1.19M 1.02M 1.28M
Other Current Assets 15.42M 9.17M 17.73M 12M n/a
Total Current Assets 438.89M 432.95M 519.29M 478.3M 409.14M
Property-Plant & Equipment 12.68M 9.14M 10.97M 12.38M 14.6M
Goodwill & Intangibles 114.1M 121.37M 18.57M 20.08M 21.56M
Total Long-Term Assets 217.31M 215.49M 114.95M 115.49M 124.31M
Total Assets 656.2M 648.44M 634.25M 593.79M 533.46M
Account Payables 3.5M 7.14M 12.69M 925K 1.05M
Deferred Revenue n/a n/a n/a n/a -5.82M
Short-Term Debt n/a n/a n/a n/a n/a
Other Current Liabilities 69.36M 69.33M 64.6M 58.8M 47.05M
Total Current Liabilities 99.98M 87.7M 91.44M 74.42M 65.94M
Long-Term Debt 8.09M n/a n/a n/a n/a
Other Long-Term Liabilities 9.59M 8.83M 6.8M 4.39M 2.76M
Total Long-Term Liabilities 17.68M 15.83M 15.61M 14.45M 14.25M
Total Liabilities 117.66M 103.53M 107.05M 88.86M 80.19M
Total Debt 12.36M 9.4M 11.14M 10.05M 13.61M
Common Stock 58K 58K 57K 56K 55K
Retained Earnings -174.29M -155.39M -157.9M -164.18M -197.33M
Comprehensive Income 74K -30K -1.19M -175K 239K
Shareholders Equity 538.55M 544.91M 527.2M 504.93M 453.27M
Total Investments 272.33M 252.44M 331.83M 380.74M 306.71M